WO2025191534 - SOLID STATE FORMS OF ZASOCITINIB AND PROCESS FOR PREPARATION THEREOF
National phase entry is expected:
Publication Number
WO/2025/191534
Publication Date
18.09.2025
International Application No.
PCT/IB2025/052723
International Filing Date
14.03.2025
Title **
[English]
SOLID STATE FORMS OF ZASOCITINIB AND PROCESS FOR PREPARATION THEREOF
[French]
FORMES À L'ÉTAT SOLIDE DE ZASOCITINIB ET LEUR PROCÉDÉ DE PRÉPARATION
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
KORDIC, Lorena
BIKIC, Antonela
Priority Data
63/565,072
14.03.2024
US
63/570,906
28.03.2024
US
63/650,435
22.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2388 | |
| EPO | Filing, Examination, Granting | 12768 | |
| Japan | Filing, Examination, Granting | 2463 | |
| South Korea | Filing, Examination, Granting | 2623 | |
| USA | Filing, Examination, Granting | 10340 |
Total:
30,582
Contact Us
Abstract[English]
Solid state forms of Zasocitinib, processes for the preparation thereof, and pharmaceutical compositions thereof.[French]
L'invention concerne des formes à l'état solide de Zasocitinib, leurs processus de préparation et des compositions pharmaceutiques associées.